Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2024

Open Access 01-12-2024 | Deep Brain Stimulation | Study Protocol

Protocol for combined N-of-1 trials to assess cerebellar neurostimulation for movement disorders in children and young adults with dyskinetic cerebral palsy

Authors: M San Luciano, C R Oehrn, S S Wang, J S Tolmie, A Wiltshire, R E Graff, J Zhu, P A Starr

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Background

Movement and tone disorders in children and young adults with cerebral palsy are a great source of disability. Deep brain stimulation (DBS) of basal ganglia targets has a major role in the treatment of isolated dystonias, but its efficacy in dyskinetic cerebral palsy (DCP) is lower, due to structural basal ganglia and thalamic damage and lack of improvement of comorbid choreoathetosis and spasticity. The cerebellum is an attractive target for DBS in DCP since it is frequently spared from hypoxic ischemic damage, it has a significant role in dystonia network models, and small studies have shown promise of dentate stimulation in improving CP-related movement and tone disorders.

Methods

Ten children and young adults with DCP and disabling movement disorders with or without spasticity will undergo bilateral DBS in the dorsal dentate nucleus, with the most distal contact ending in the superior cerebellar peduncle. We will implant Medtronic Percept, a bidirectional neurostimulator that can sense and store brain activity and deliver DBS therapy. The efficacy of cerebellar DBS in improving quality of life and motor outcomes will be tested by a series of N-of-1 clinical trials. Each N-of-1 trial will consist of three blocks, each consisting of one month of effective stimulation and one month of sham stimulation in a random order with weekly motor and quality of life scales as primary and secondary outcomes. In addition, we will characterize abnormal patterns of cerebellar oscillatory activity measured by local field potentials from the intracranial electrodes related to clinical assessments and wearable monitors. Pre- and 12-month postoperative volumetric structural and functional MRI and diffusion tensor imaging will be used to identify candidate imaging markers of baseline disease severity and response to DBS.

Discussion

Our goal is to test a cerebellar neuromodulation therapy that produces meaningful changes in function and well-being for people with CP, obtain a mechanistic understanding of the underlying brain network disorder, and identify physiological and imaging-based predictors of outcomes useful in planning further studies.

Trial registration

ClinicalTrials.gov NCT06122675, first registered November 7, 2023.
Literature
1.
2.
Vitrikas K, Dalton H, Breish D. Cerebral palsy: an overview. Am Fam Physician. 2020;101(4):213–20.PubMed
3.
Termsarasab P. Medical treatment of dyskinetic cerebral palsy: translation into practice. Dev Med Child Neurol. 2017;59(12):1210. 20170911th ed.CrossRefPubMed
4.
Himmelmann K, McManus V, Hagberg G, Uvebrant P, Krägeloh-Mann I, Cans C. Dyskinetic cerebral palsy in Europe: trends in prevalence and severity. Arch Child. 20090512th ed. 2009;94(12):921–6.
5.
Bohn E, Goren K, Switzer L, Falck-Ytter Y, Fehlings D. Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis. Dev Med Child Neurol. 2021;63(9):1038–50. 20210327th ed.CrossRefPubMedPubMedCentral
6.
Monbaliu E, Himmelmann K, Lin JP, Ortibus E, Bonouvrie L, Feys H, et al. Clinical presentation and management of dyskinetic cerebral palsy. Lancet Neurol. 2017;16(9):741–9.CrossRefPubMed
7.
Hasnat MJ, Rice JE. Intrathecal baclofen for treating spasticity in children with cerebral palsy. Cochrane Database Syst Rev. 2015;2015(11):Cd004552. 20151113th ed.PubMedPubMedCentral
8.
an de Pol LA, Vermeulen RJ, van ’t Westende C, van Schie PEM, Bolster EAM, van Ouwerkerk P, et al. Risk factors for Dystonia after selective dorsal rhizotomy in Nonwalking Children and adolescents with bilateral spasticity. Neuropediatrics. 2018;49(1):44–50. 20171107th ed.CrossRefPubMed
9.
San Luciano M, Robichaux-Viehoever A, Dodenhoff KA, Gittings ML, Viser AC, Racine CA, et al. Thalamic deep brain stimulation for acquired dystonia in children and young adults: a phase 1 clinical trial. J Neurosurg Pediatr. 2020;27(2):203–12. 20201127th ed.CrossRefPubMed
10.
Vidailhet M, Yelnik J, Lagrange C, Fraix V, Grabli D, Thobois S et al. Bilateral pallidal deep brain stimulation for the treatment of patients with dystonia-choreoathetosis cerebral palsy: a prospective pilot study. Lancet Neurol. 20090701st ed. 2009;8(8):709–17.
11.
Miocinovic S, Somayajula S, Chitnis S, Vitek JL. History, applications, and mechanisms of deep brain stimulation. JAMA Neurol. 2013;70(2):163–71.CrossRefPubMed
12.
Koy A, Hellmich M, Pauls KA, Marks W, Lin JP, Fricke O, et al. Effects of deep brain stimulation in dyskinetic cerebral palsy: a meta-analysis. Mov Disord. 2013;28(5):647–54. 20130213th ed.CrossRefPubMed
13.
Koy A, Kuhn AA, Huebl J, Schneider GH, van Riesen AK, Eckenweiler M et al. Quality of Life After Deep Brain Stimulation of Pediatric Patients with Dyskinetic Cerebral Palsy: A Prospective, Single-Arm, Multicenter Study with a Subsequent Randomized Double-Blind Crossover (STIM-CP). Mov Disord. 20211229th ed. 2022;37(4):799–811.
14.
Koy A, Timmermann L. Deep brain stimulation in cerebral palsy: challenges and opportunities. Eur J Paediatr Neurol. 2017;21(1):118–21. 20160527th ed.CrossRefPubMed
15.
Prudente CN, Hess EJ, Jinnah HA. Dystonia as a network disorder: what is the role of the cerebellum? Neuroscience. 20131211th ed. 2014;260:23–35.
16.
Bax M, Tydeman C, Flodmark O. Clinical and MRI correlates of cerebral palsy: the European cerebral Palsy Study. JAMA. 2006;296(13):1602–8.CrossRefPubMed
17.
Wong JK, Mayberg HS, Wang DD, Richardson RM, Halpern CH, Krinke L et al. Proceedings of the 10th annual deep brain stimulation think tank: Advances in cutting edge technologies, artificial intelligence, neuromodulation, neuroethics, interventional psychiatry, and women in neuromodulation. Front Hum Neurosci. 20230127th ed. 2022;16:1084782.
18.
Cooper IS, Riklan M, Amin I, Waltz JM, Cullinan T. Chronic cerebellar stimulation in cerebral palsy. Neurology. 1976;26(8):744–53.CrossRefPubMed
19.
Guidetti B, Fraioli B. Neurosurgical treatment of spasticity and dyskinesias. Acta Neurochir Wien. 1977;(Suppl 24):27–39.
20.
Heimburger RF, Whitlock CC. Stereotaxic destruction of the human dentate nucleus. Confin Neurol. 1965;26(3):346–58.CrossRefPubMed
21.
Krayenbuhl H, Siegfried J. Dentatotomies or thalamotomies in the treatment of hyperkinesia. Confin Neurol. 1972;34(1):29–33.CrossRefPubMed
22.
Davis R. Cerebellar stimulation for cerebral palsy spasticity, function, and seizures. Arch Med Res. 2000;31(3):290–9.CrossRefPubMed
23.
Brown EG, Bledsoe IO, Luthra NS, Miocinovic S, Starr PA, Ostrem JL. Cerebellar deep brain stimulation for Acquired Hemidystonia. Mov Disord Clin Pr. 2020;7(2):188–93. 20200108th ed.CrossRef
24.
Cajigas I, Morrison MA, Luciano MS, Starr PA. Cerebellar deep brain stimulation for the treatment of movement disorders in cerebral palsy. J Neurosurg. 20230210th ed. 2023;1–10.
25.
Galanda M, Horvath S. Stereotactic stimulation of the anterior lobe of the cerebellum in cerebral palsy from a suboccipital approach. Acta Neurochir Suppl. 2007;97(Pt 2):239–43.CrossRefPubMed
26.
Horisawa S, Kohara K, Nonaka T, Mochizuki T, Kawamata T, Taira T. Case Report: Deep Cerebellar Stimulation for Tremor and Dystonia. Front Neurol. 20210305th ed. 2021;12:642904.
27.
Sokal P, Rudas M, Harat M, Szylberg L, Zielinski P. Deep anterior cerebellar stimulation reduces symptoms of secondary dystonia in patients with cerebral palsy treated due to spasticity. Clin Neurol Neurosurg. 2015;135:62–8. 20150523rd ed.CrossRefPubMed
28.
29.
Shamseer L, Sampson M, Bukutu C, Schmid CH, Nikles J, Tate R, et al. CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration. J Clin Epidemiol. 2016;76:18–46.CrossRefPubMed
30.
Ahalt C, Sudore R, Bolano M, Metzger L, Darby AM, Williams B. Teach-to-goal to Better Assess Informed Consent Comprehension among incarcerated clinical research participants. AMA J Ethics. 2017;19(9):862–72.CrossRefPubMedPubMedCentral
31.
Chiong W, Leonard MK, Chang EF. Neurosurgical patients as human research subjects: ethical considerations in Intracranial Electrophysiology Research. Neurosurgery. 2018;83(1):29–37.CrossRefPubMed
32.
Sudore R, Landefeld C, Williams B, Barnes D, Lindquist K, Schillinger D. Use of a modified informed consent process among vulnerable patients: a descriptive study. J Gen Intern Med. 2006;21(9):1009.CrossRefPubMedCentral
33.
Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol. 2006;48(10):804–12.CrossRefPubMed
34.
Battini R, Sgandurra G, Menici V, Scalise R, Olivieri I, Di Pietro R, et al. Movement disorders - Childhood Rating Scale 4–18 revised in children with dyskinetic cerebral palsy. Eur J Phys Rehabil Med. 2020;56(3):272–8. 20200123rd ed.CrossRefPubMed
35.
Senn S. Sample size considerations for n-of-1 trials. Stat Methods Med Res. 2019;28(2):372–83. 20170907th ed.CrossRefPubMed
36.
Jordan C, Geisel G, Alecu JE, Zhang B, Sahin M, Ebrahimi-Fakhari D. Disease Severity and Motor Impairment Correlate With Health-Related Quality of Life in AP-4-Associated Hereditary Spastic Paraplegia. Neurol Genet. 20210720th ed. 2021;7(4):e605.
37.
Tai CH, Tseng SH. Cerebellar deep brain stimulation for movement disorders. Neurobiol Dis. 20221018th ed. 2022;175:105899.
38.
Gupta S, Faughnan ME, Tomlinson GA, Bayoumi AM. A framework for applying unfamiliar trial designs in studies of rare diseases. J Clin Epidemiol. 2011;64(10):1085–94.CrossRefPubMed
39.
Tate RL, Perdices M. Research note: single-case experimental designs. J Physiother. 2020;66(3):202–6.CrossRefPubMed
40.
Green AL, Shad A, Watson R, Nandi D, Yianni J, Aziz TZ. N-of-1 trials for assessing the efficacy of Deep Brain Stimulation in Neuropathic Pain. Neuromodulation J Int Neuromodulation Soc. 2004;7(2):76–81.CrossRef
41.
Mendonça M, Cotovio G, Barbosa R, Grunho M, Oliveira-Maia AJ. An argument in Favor of Deep Brain Stimulation for Uncommon Movement disorders: the case for N-of-1 trials in Holmes Tremor. Front Hum Neurosci. 2022;16:921523.CrossRefPubMedPubMedCentral
42.
Tonge M, Ackermans L, Kocabicak E, van Kranen-Mastenbroek V, Kuijf M, Oosterloo M, et al. A detailed analysis of intracerebral hemorrhages in DBS surgeries. Clin Neurol Neurosurg. 2015;139:183–7.CrossRefPubMed
43.
Kaminska M, Perides S, Lumsden DE, Nakou V, Selway R, Ashkan K, et al. Complications of Deep Brain Stimulation (DBS) for dystonia in children - the challenges and 10 year experience in a large paediatric cohort. Eur J Paediatr Neurol. 2017;21(1):168–75. 20160803rd ed.CrossRefPubMed
44.
Jimenez-Shahed J. Device profile of the percept PC deep brain stimulation system for the treatment of Parkinson’s disease and related disorders. Expert Rev Med Devices. 2021;18(4):319–32. 20210405th ed.CrossRefPubMed
45.
Davidson B, Elkaim LM, Lipsman N, Ibrahim GM. Editorial. An ethical framework for deep brain stimulation in children. Neurosurg Focus. 2018;45(3):E11.CrossRefPubMed
46.
Lin JP, Lumsden DE, Gimeno H, Kaminska M. The impact and prognosis for dystonia in childhood including dystonic cerebral palsy: a clinical and demographic tertiary cohort study. J Neurol Neurosurg Psychiatry. 2014;85(11):1239–44. 20140303rd ed.CrossRefPubMed
Metadata
Title
Protocol for combined N-of-1 trials to assess cerebellar neurostimulation for movement disorders in children and young adults with dyskinetic cerebral palsy
Authors
M San Luciano
C R Oehrn
S S Wang
J S Tolmie
A Wiltshire
R E Graff
J Zhu
P A Starr
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03633-z

Other articles of this Issue 1/2024

BMC Neurology 1/2024 Go to the issue

Case Report

Aneurysmal subarachnoid hemorrhage complicating spinal subarachnoid hematoma causing acute cauda equina syndrome: a case report

Research

Validity of the modified Rankin Scale in patients with aneurysmal subarachnoid hemorrhage: a randomized study

Study Protocol

Development of a smartphone screening test for preclinical Alzheimer’s disease and validation across the dementia continuum

Case Report

Guillain–Barre syndrome following scrub typhus: a case report and literature review

Case Report

Fabry disease in W162C mutation: a case report of two patients and a review of literature

Study Protocol

Don’t be late! Timely identification of cognitive impairment in people with multiple sclerosis: a study protocol